Cargando…
Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
BACKGROUND: Molecular characteristics are essential for the classification and grading of gliomas. However, diagnostic classification of midline glioma is still debatable and substantial molecular and clinical heterogeneity within each subgroup suggested that they should be further stratified. Here,...
Autores principales: | Li, Hainan, Shan, Changguo, Wu, Shengnan, Cheng, Baijie, Fan, Chongzu, Cai, Linbo, Chen, Yedan, Shi, Yuqian, Liu, Kaihua, Shao, Yang, Zhu, Dan, Li, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968371/ https://www.ncbi.nlm.nih.gov/pubmed/33747896 http://dx.doi.org/10.3389/fonc.2020.607429 |
Ejemplares similares
-
Bone metastases in an adult patient with diffuse midline glioma: a case report
por: Li, Shaoqun, et al.
Publicado: (2020) -
Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas
por: Vuong, Huy Gia, et al.
Publicado: (2022) -
EGFR amplification is a putative resistance mechanism for NSCLC–LM patients with TKI therapy and is associated with poor outcome
por: Yang, Hainan, et al.
Publicado: (2022) -
HGG-33. Prognostic factors of H3K27M histone-mutant diffuse midline gliomas in patients ≤18yrs
por: Hu, Qingjun, et al.
Publicado: (2022) -
Increased M1 Macrophages Infiltration Correlated With Poor Survival Outcomes and Radiation Response in Gliomas
por: Zhou, Zhaoming, et al.
Publicado: (2020)